glp-1 liver enzymes Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty disease (NAFLD): A systematic review - Lv - 2020 - Endocrinology, Diabetes & Metabolism GLP-1 receptor agonists may protect

Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function

On Wellness Hour, Beth Collings, a nurse practitioner with more than a decade of experience in primary care and emergency medicine, joined us to explain how these medications work, who may benefit, and what to consider before starting

Dulaglutide (Weekly Injection) Dulaglutide is another weekly injectable GLP-1 option

We show (i) that PfGrx-catalyzed redox reactions outcompete uncatalyzed reactions between roGFP2 and GSH or GSSG by several orders of magnitude, (ii) that the PfGrx-catalyzed reduction and oxidation of roGFP2 occur via a mono- and not a dithiol mechanism, and (iii) that the reduction of roGFP2(S 2 ) as a model non-glutathione disulfide substrate most likely involves a rate-limiting glutathionylation in a ternary complex with a GSH molecule that is activated at the 1st glutathione-interaction site of PfGrx